Kenneth A. Custer, Age 49, passed away on February 12, 2018. Cherished son of the late Richard H. and the late Estelle K. Custer. Dear grandson of the late Harry and the late Alice Custer. Loving b… ...

By Deena Beasley (Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them ...

Eli Lilly says it plans to apply for U.S. Food and Drug Administration (FDA) approval by the end of the year to market the ...

Kenneth Custer, executive vice president and president, Lilly Cardiometabolic Health, said: “The SURPASS-CVOT results show ...

Eli Lilly, the pharmaceutical company behind GLP-1 injection Zepbound, is working to bring its weight loss drug to the market in pill form. In an Aug. 7 earnings call, Eli Lilly C ...

Kenneth George Custer passed away on June 2, 2024, at the age of 73 in Little Rock, Ark. He was born August 25, 1950, in Livingston, Mont. Ken was a beloved husband, loyal friend, and mentor who ...

Trials of a daily obesity pill have shown it can help patients lose around 12% of their body weight over 72 weeks. The ...

Eli Lilly says their obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

A court has ordered that more than £18,000 in cash found in a wardrobe at a drug dealer’s home be donated to charity. Police ...

Eli Lilly’s GIP/GLP-1 dual receptor agonist Mounjaro (tirzepatide) has demonstrated cardiovascular protection in a late-stage ...